No Data
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
H.C. Wainwright Initiates Artiva Biotherapeutics(ARTV.US) With Buy Rating, Announces Target Price $20
Artiva Biotherapeutics Reports Q3 2024 Financial Results
Express News | Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target
Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability
Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From TD Cowen
No Data
Wins333 : when were you in? when it was falling or rising?